SGCE missense mutations that cause myoclonus-dystonia syndrome impair ε-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA
<p>Myoclonus-dystonia syndrome (MDS) is a genetically heterogeneous disorder characterized by myoclonic jerks often seen in combination with dystonia and psychiatric co-morbidities and epilepsy. Mutations in the gene encoding ε-sarcoglycan (<em>SGCE</em>) have been found in some pa...
Автори: | Esapa, C, Waite, A, Locke, M, Benson, M, Kraus, M, McIlhinney, R, Sillitoe, R, Beesley, P, Blake, D |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Oxford University Press
2007
|
Предмети: |
Схожі ресурси
Схожі ресурси
-
Advances in molecular and cell biology of dystonia: Focus on torsinA
за авторством: Pedro Gonzalez-Alegre
Опубліковано: (2019-07-01) -
Gait Impairment in Myoclonus–Dystonia (DYT-SGCE)
за авторством: Ghazal Haeri, та інші
Опубліковано: (2019-08-01) -
ANALYZING THE EXPRESSION OF Ε-SARCOGLYCAN (SGCE) ISOFORMS IN BRAIN
за авторством: Ana Cazurro-Gutiérrez, та інші
Опубліковано: (2023-10-01) -
Myoclonus-Dystonia Syndrome and E-Sarcoglycan Deficiency
за авторством: J Gordon Millichap
Опубліковано: (2002-10-01) -
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion
за авторством: Kevin Rostasy, та інші
Опубліковано: (2003-02-01)